Quan M. Zhao

No.157 Jinbi Road
Kunming, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 76 publications

Non-familiar type 1 Andersen-Tawil syndrome in 4 children

Non-familiar type 1 Andersen-Tawil syndrome in 4 children

Journal: Zhonghua er ke za zhi = Chinese journal of pediatrics

Published: May 14, 2026

Effectiveness and safety of rivaroxaban in pediatric patients with coronary artery diseases: a case series study

Effectiveness and safety of rivaroxaban in pediatric patients with coronary artery diseases: a case series study

Journal: Zhonghua er ke za zhi = Chinese journal of pediatrics

Published: March 16, 2026

The novel retinoid WYC-209 sensitizes multiple myeloma to carfilzomib via epigenetically upregulating ZMYND8.

The novel retinoid WYC-209 sensitizes multiple myeloma to carfilzomib via epigenetically upregulating ZMYND8.

Journal: Experimental hematology & oncology

Published: January 03, 2026

Enhanced immunotherapy efficacy through molecularly imprinted nanoparticles co-targeting cluster of differentiation-73 and programmed death-ligand 1.

Enhanced immunotherapy efficacy through molecularly imprinted nanoparticles co-targeting cluster of differentiation-73 and programmed death-ligand 1.

Journal: Acta biomaterialia

Published: October 02, 2025

Protein kinase B inhibitors enhance the sensitivity of translocated promoter region-fibroblast growth factor receptor 1 cells to fibroblast growth factor receptor 1 inhibitor-induced apoptosis.

Protein kinase B inhibitors enhance the sensitivity of translocated promoter region-fibroblast growth factor receptor 1 cells to fibroblast growth factor receptor 1 inhibitor-induced apoptosis.

Journal: The Journal of international medical research

Published: August 05, 2025

Noncanonical role of KDM5C in conferring bortezomib resistance via the PERK‒Nrf2 axis in multiple myeloma.

Noncanonical role of KDM5C in conferring bortezomib resistance via the PERK‒Nrf2 axis in multiple myeloma.

Journal: Cell death & disease

Published: August 01, 2025

Discovery of a Novel DNMT1 Inhibitor with Improved Efficacy in Treating β-Thalassemia.

Discovery of a Novel DNMT1 Inhibitor with Improved Efficacy in Treating β-Thalassemia.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: July 17, 2025

Zhi-Zi-Chi decoction ameliorates depression-like behavior in chronic unpredictable mild stress-induced mice via the PI3K/AKT/mTOR signaling pathway.

Zhi-Zi-Chi decoction ameliorates depression-like behavior in chronic unpredictable mild stress-induced mice via the PI3K/AKT/mTOR signaling pathway.

Journal: Journal of ethnopharmacology

Published: March 27, 2025

Lipid droplets deposition in perihematoma tissue is associated with neurological dysfunction after intracerebral hemorrhage.

Lipid droplets deposition in perihematoma tissue is associated with neurological dysfunction after intracerebral hemorrhage.

Journal: Neuroreport

Published: February 20, 2025

Analysis of 41 cases of myocardial infarction in children with coronary artery lesion after Kawasaki disease

Analysis of 41 cases of myocardial infarction in children with coronary artery lesion after Kawasaki disease

Journal: Zhonghua er ke za zhi = Chinese journal of pediatrics

Published: January 23, 2025

NONO interacts with nuclear PKM2 and directs histone H3 phosphorylation to promote triple-negative breast cancer metastasis.

NONO interacts with nuclear PKM2 and directs histone H3 phosphorylation to promote triple-negative breast cancer metastasis.

Journal: Journal of experimental & clinical cancer research : CR

Published: December 14, 2024

Relationship between clopidogrel resistance and genetic variability in Kawasaki disease children with coronary artery lesions

Relationship between clopidogrel resistance and genetic variability in Kawasaki disease children with coronary artery lesions

Journal: Zhonghua er ke za zhi = Chinese journal of pediatrics

Published: September 27, 2024

Showing 1-12 of 76

Last Updated: 09/26/2026